- •Preface
- •Contents
- •1.1.1 The Vitreous
- •1.1.1.1 Embryology
- •1.1.1.2 The Anatomy
- •1.1.1.3 Anatomical Attachments of the Vitreous to the Surrounding Structures
- •1.1.2 The Retina
- •1.1.2.1 Embryology
- •1.1.2.2 Anatomy
- •Retinal Pigment Epithelium (RPE)
- •Photoreceptor Layer
- •Intermediary Neurones
- •Ganglion Cells
- •Retinal Blood Vessels
- •Other Fundal Structures
- •1.1.3 The Physiology of the Vitreous
- •1.2 Clinical Examination and Investigation
- •1.2.1 Using the Database
- •1.2.2 Examination of the Eye
- •1.2.2.1 Examination Technique
- •Visual Acuity
- •1.2.2.2 The Slit Lamp
- •1.2.2.3 Binocular Indirect Ophthalmoscope
- •1.2.2.4 Using the Indenter
- •1.2.2.5 Ultrasonography
- •Posterior Vitreous Detachment (PVD)
- •Retinal Tear
- •Retinal Detachment
- •Subretinal Haemorrhage
- •Retinoschisis
- •Choroidal Elevation
- •Trauma
- •1.2.2.6 Optical Coherence Tomography
- •Time-Domain OCT
- •Colour Coding
- •Frequency-Domain OCT
- •Full-Field OCT
- •Scan Resolution
- •Images and Measurements
- •Performing the Scan
- •Macular Scan Patterns
- •Central Retinal Thickness
- •Inner Segment and Outer Segment Junction and External Limiting Membrane
- •1.2.3 Subjective Tests
- •1.2.4 The Preoperative Assessment
- •1.3 Summary
- •References
- •2: Introduction to Vitreoretinal Surgery
- •2.1 Introduction
- •2.2 Choice of Anaesthesia
- •2.3 Pars Plana Vitrectomy
- •2.3.1 Sclerotomies
- •2.3.2 Where to Place the Sclerotomies
- •2.3.3 Securing the Infusion Cannula
- •2.3.4 Checking the Infusion
- •2.3.6 The Superior Sclerotomies
- •2.3.6.1 Where to Place
- •2.3.7 Checking the View
- •2.3.8 The Independent Viewing System
- •2.3.9 Removing the Vitreous
- •2.4 Vitrectomy Cutters
- •2.5 Handling the Light Pipe
- •2.6 Use of Sclerotomy Plugs
- •2.7 The Internal Search
- •2.8 Endolaser
- •2.9 Using a Contact Lens
- •2.10 Maintaining a View
- •2.10.1 Microscope
- •2.10.3 Cornea
- •2.10.4 Blood in the Anterior Chamber
- •2.10.5 Condensation on an Intraocular Lens Implant
- •2.10.6 Cataract Formation
- •2.10.7 Pupillary Dilation
- •2.11 Closing
- •2.12 Peroperative Complications
- •2.12.1 Iatrogenic Breaks
- •2.12.1.1 Causes
- •2.12.2 Choroidal Haemorrhage
- •2.12.3 Haemorrhage from Retinal or Other Blood Vessels
- •2.12.4 Lens Touch
- •2.12.5 Hypotony
- •2.13 Postoperative Complications
- •2.13.1 Cataract
- •2.13.2 Endophthalmitis
- •2.13.3 Corneal Changes
- •2.13.4 Choroidal Haemorrhage
- •2.13.5 Raised Intraocular Pressure
- •2.13.6 Retinal Breaks and RRD
- •2.13.7 Hypotony
- •2.13.8 Scleritis
- •2.13.9 Sympathetic Uveitis
- •2.14 Adjustments for 20 Gauge Vitrectomy
- •2.14.1 Construction of Superior Sclerotomies
- •2.14.2 Priming
- •2.14.3 Self-Sealing Sclerotomies
- •2.15 Adjustments for 23 and 25 Gauge Vitrectomy
- •2.15.1 Instrumentation
- •2.15.2 Surgical Technique
- •2.15.2.1 Vitrectomy Technique
- •2.15.3 Flexibility
- •2.15.4 Indentation
- •2.15.5 Flow Rates
- •2.15.6 Trochar Internal Protrusion
- •2.15.7 Silicone Oil
- •2.16 Complications
- •2.16.1 Peroperative
- •2.16.1.1 Extrusion of the Trochar on Removal of Instrumentation
- •2.16.1.2 Conjunctival Chemosis
- •2.16.1.3 Hypotony
- •2.16.1.4 Endophthalmitis
- •2.16.2 Postoperative Retinal Break Formation
- •2.17 Advantages and Disadvantages of 23 and 25 G Systems
- •2.18 Combined Cataract Extraction and PPV
- •2.18.1 How to Decide Whether to Perform Combined Surgery
- •2.18.1.1 Accommodation
- •2.19 Biometry
- •2.20 Chandelier Systems and Bimanual Surgery
- •2.20.1 Possible Complications
- •2.21 Dyes
- •2.22 Intravitreal Injections
- •2.22.1 Injection Medications
- •2.23 Slow Release Preparations
- •2.24 Summary
- •References
- •3: Principles of Internal Tamponade
- •3.1 Gases
- •3.1.1 Principles
- •3.1.1.1 Properties
- •3.1.1.2 A Safe Method for Drawing Up Gas
- •3.1.2 Complications
- •3.1.2.1 Vision
- •3.1.2.2 Refraction
- •3.1.2.3 Cataract
- •3.1.2.5 Loss of the Gas Bubble
- •3.1.2.6 Gas in the Wrong Place
- •3.1.3 Important Postoperative Information
- •3.1.3.1 Flying or Travel to High Altitude
- •3.1.3.2 General Anaesthesia
- •3.2 Silicone Oil
- •3.2.1 Properties
- •3.2.3 Complications of Silicone Oil
- •3.2.3.1 Refractive Changes
- •3.2.3.2 Cataract
- •3.2.3.5 Cornea
- •3.2.3.6 Macular Toxicity
- •3.2.3.7 Oil in the Wrong Place
- •3.2.3.8 Emulsion
- •3.2.3.9 IOLs
- •3.2.4 Silicone Oil Removal
- •3.2.4.1 Alternative Methods
- •3.2.4.2 Retinal Redetachment Rates After Oil Removal
- •3.2.5 Heavy Silicone Oils
- •3.2.6 Heavy Liquids
- •3.2.7 ‘Light’ Heavy Liquids
- •3.3 Summary
- •References
- •4: Posterior Vitreous Detachment
- •4.1 Introduction
- •4.1.1 Symptoms
- •4.1.1.1 Floaters
- •4.1.1.2 Flashes
- •Introduction
- •Clinical Characteristics
- •4.1.2 Signs
- •4.1.2.1 Detection of PVD
- •4.1.2.2 Shafer’s Sign
- •4.1.2.3 Vitreous Haemorrhage
- •4.1.2.4 Ophthalmoscopy
- •4.1.3 Retinal Tears
- •4.1.3.1 U Tears
- •4.1.3.2 Atrophic Round Holes
- •4.1.3.3 Other Breaks
- •4.1.3.4 Progression to Retinal Detachment
- •4.1.4 Peripheral Retinal Degenerations
- •4.2 Summary
- •References
- •5: Vitreous Haemorrhage
- •5.1 Introduction
- •5.2 Aetiology
- •5.3 Natural History
- •5.4 Erythroclastic Glaucoma
- •5.5 Investigation
- •5.6 Ultrasound
- •5.7 Management
- •5.8 Surgery
- •5.9 Vitrectomy
- •5.10 Summary
- •References
- •6: Rhegmatogenous Retinal Detachment
- •6.1 Introduction
- •6.1.1 Tears with Posterior Vitreous Detachment
- •6.1.2 Breaks Without Posterior Vitreous Detachment
- •6.1.3 Natural History
- •6.1.3.1 Chronic RRD
- •6.1.3.2 Risk to the Other Eye
- •6.2 Clinical Features
- •6.2.1 Anterior Segment Signs
- •6.2.2 Signs in the Vitreous
- •6.2.3 Subretinal Fluid Accumulation
- •6.2.4 Retinal Break Patterns in RRD
- •6.2.5 Macula Off or On
- •6.3 Surgery
- •6.3.1 Flat Retinal Breaks
- •6.3.1.1 Retinopexy
- •6.3.1.2 Cryotherapy
- •6.3.1.3 Cryotherapy in the Clinic Setting
- •6.3.1.4 Laser
- •6.3.1.5 Laser in the Clinic Setting
- •6.3.2 Retinal Detachment
- •6.3.2.1 Principles
- •6.3.2.2 Break Closure
- •6.3.2.3 Relief of Traction
- •6.3.2.4 Alteration of Fluid Currents
- •6.3.2.5 Retinopexy
- •6.3.3 Pars Plana Vitrectomy
- •6.3.3.1 Introduction
- •6.3.3.2 Finding the Breaks
- •6.3.3.4 Draining Subretinal Fluid
- •6.3.3.5 When to Use Heavy Liquids
- •6.3.3.6 Removal of Heavy Liquid
- •6.3.3.7 Choice of Tamponade
- •6.3.3.8 Avoiding Retinal Folds
- •6.3.3.9 Inferior Breaks
- •6.3.3.10 Posterior Breaks
- •6.3.3.11 Multiple Breaks
- •6.3.3.12 Medial Opacities
- •6.3.3.13 Complications
- •6.3.3.14 Surgery for Eyes with No Breaks Found
- •6.3.3.15 Use of 360° Laser or Routine 360° Encirclage
- •6.3.3.16 Posturing
- •6.3.4.1 Operative Stages
- •6.3.4.2 Postoperative Care
- •6.3.4.3 Complications
- •6.3.4.4 Peroperative
- •6.3.4.5 Postoperative
- •6.3.5 Drainage Air Cryotherapy and Explant (DACE)
- •6.3.5.1 Subretinal Fluid (SRF) Drainage
- •6.3.5.2 Air Insertion
- •6.3.5.3 Complications
- •6.3.6 Pneumatic Retinopexy
- •6.3.6.1 Surgical Steps
- •6.3.6.2 Complications
- •6.4 Success Rates
- •6.5 Causes of Failure
- •6.6 Surgery for Redetachment
- •6.7 Secondary Macular Holes
- •6.8 Detachment with Choroidal Effusions
- •6.9 Removal of Explant
- •6.9.1 Diplopia
- •6.9.2 Erosion Through Conjunctiva
- •6.9.3 Infection
- •6.9.4 Cosmesis
- •6.9.5 Irritation
- •6.9.6 Surgery for Removal of the Explant
- •6.10 Summary
- •References
- •7.2 Atrophic Hole RRD with Attached Vitreous
- •7.3 Pseudophakic RRD
- •7.4 Aphakic RRD
- •7.5 Retinal Dialysis
- •7.5.1 Clinical Features
- •7.5.2 Surgery for Retinal Dialysis
- •7.5.2.1 Search
- •7.5.2.2 Cryotherapy
- •7.5.2.3 Marking the Break
- •7.5.2.4 Plombage
- •7.5.2.5 Checking the Indent
- •7.5.3 Complications
- •7.5.4 Giant Retinal Dialysis
- •7.5.5 Dialysis and PVR
- •7.5.6 Par Ciliaris Tear
- •7.6 Giant Retinal Tear
- •7.6.1 Clinical Features
- •7.6.2 Stickler’s Syndrome
- •7.6.3 Surgery for Giant Retinal Tear
- •7.6.3.1 Heavy Liquids
- •7.6.3.2 Retinopexy
- •7.6.3.3 Trans-scleral Illumination Technique
- •7.6.3.4 Silicone Oil Insertion
- •7.6.3.5 Choice of Endotamponade
- •7.6.3.6 Success Rates
- •7.6.3.7 Removal of the Silicone Oil
- •7.6.3.8 The Other Eye
- •7.7 Retinal Detachment in High Myopes
- •7.7.1 Clinical Features
- •7.7.2 Surgery
- •7.8.1 Clinical Features
- •7.8.1.1 Infantile Retinoschisis
- •7.8.1.2 Senile Retinoschisis
- •7.8.1.4 Retinal Detachment in Retinoschisis
- •7.8.2 Surgery
- •7.9 Juvenile Retinal Detachment
- •7.10 Atopic Dermatitis
- •7.11 Refractive Surgery
- •7.12 Congenital Cataract
- •7.13 Others
- •7.14 Summary
- •References
- •8: Proliferative Vitreoretinopathy
- •8.1 Introduction
- •8.2 Pathogenesis
- •8.3 Clinical Features
- •8.3.1 Introduction
- •8.3.2 Grading
- •8.3.3 Risk of PVR
- •8.4 Surgery
- •8.4.1 Mild PVR
- •8.4.2 Moderate PVR
- •8.4.3 Severe PVR
- •8.4.3.1 The Relieving Retinectomy
- •8.4.4 Radial Retinotomy
- •8.4.5 Silicone Oil Injection
- •8.4.6 Applying Laser
- •8.4.7 ROSO Plus
- •8.4.8 Very Severe PVR
- •8.4.9 Choice of Endotamponade
- •8.4.9.1 Silicone Oil or Perfluoropropane Gas
- •8.4.9.2 Heavy Oils
- •8.4.10 Removal of Subretinal Bands
- •8.4.11 Adjunctive Therapies
- •8.4.12 Success Rates
- •8.4.13 Postoperative Complications
- •8.5 Summary
- •References
- •9: Macular Hole
- •9.1 Introduction
- •9.2 Idiopathic Macular Hole
- •9.2.1 Clinical Features
- •9.2.1.1 Introduction
- •9.2.1.2 Watzke–Allen Test
- •9.2.1.3 Grading
- •9.2.1.4 Natural History
- •9.2.1.5 Optical Coherence Tomography
- •9.2.2 Secondary Macular Holes
- •9.2.3 Lamellar and Partial Thickness Holes
- •9.2.4 Surgery
- •9.2.4.1 Introduction
- •9.2.4.2 Surgery
- •9.2.4.3 Peeling the Posterior Hyaloid Membrane
- •9.2.4.4 ILM Peel and Other Adjunctive Therapies
- •9.2.4.5 Choice of Tamponade
- •9.2.4.6 Postoperative Posturing of the Patient
- •9.2.4.9 Visual Field Loss
- •9.2.5 Success Rates
- •9.2.6 Reoperation
- •9.3 Microplasmin
- •9.4 Summary
- •References
- •10.1 Clinical Features
- •10.1.1 Other Conditions
- •10.1.2 Secondary Macular Pucker
- •10.2 Surgery
- •10.3 Success Rates
- •10.5 Membrane Recurrence
- •10.6 Summary
- •References
- •11: Choroidal Neovascular Membrane
- •11.1 Age-Related Macular Degeneration
- •11.1.1 Clinical Features
- •11.1.2 Vitreous Haemorrhage and CNV
- •11.1.3 Pneumatic Displacement of Subretinal Haemorrhage
- •11.1.4 Surgery for Failed Anti-VEGF Therapy
- •11.1.4.1 Introduction
- •11.1.4.2 360° Macular Translocation
- •11.1.6 Success Rates
- •11.2 Choroidal Neovascular Membrane Not from ARMD
- •11.2.1 Introduction
- •11.2.2 Surgery
- •11.3 Summary
- •References
- •12: Diabetic Retinopathy
- •12.1 Introduction
- •12.2 Diabetic Retinopathy
- •12.2.1 Introduction
- •12.2.1.1 Diabetic Retinopathy Grading
- •12.2.2 Diabetic Vitreous Haemorrhage
- •12.2.3 Progression to Vitreous Haemorrhage and Tractional Retinal Detachment
- •12.2.3.1 Clinical Features
- •12.2.3.2 Surgery
- •12.2.4 Diabetic Retinal Detachment
- •12.2.4.1 Clinical Features
- •12.2.4.2 Surgery
- •12.2.4.3 Tractional Retinal Detachment
- •12.2.4.4 Peroperative Panretinal Photocoagulation
- •12.2.4.6 Bimanual Surgery
- •12.2.4.7 Dealing with Bleeding Vessels
- •12.2.4.8 Iatrogenic Breaks
- •12.2.4.9 Silicone Oil
- •12.2.4.10 Combined TRD and RRD
- •12.2.5 Postoperative Complications
- •12.2.5.1 Vitreous Haemorrhage
- •12.2.5.2 Rhegmatogenous Retinal Detachment
- •12.2.5.3 Iris Neovascularisation
- •12.2.5.4 Phthisis Bulbi
- •12.2.5.5 Maculopathy
- •12.2.5.6 Survival After Surgery
- •12.2.6 Success Rates
- •12.2.7 Diabetic Maculopathy
- •References
- •13: Other Vascular Disorders
- •13.1 Introduction
- •13.2 Retinal Vein Occlusion
- •13.2.1 Chorioretinal Anastomosis
- •13.2.2 Arteriovenous Decompression
- •13.2.3 Radial Optic Neurotomy
- •13.2.4 Intravitreal Steroid and Anti-VEGF Agents
- •13.2.5 Tissue Plasminogen Activator
- •13.3 Sickle-Cell Disease
- •13.3.1 Introduction
- •13.3.2 Types of Sickle-Cell Disease
- •13.3.3 Systemic Investigation
- •13.3.4 Inheritance and Race
- •13.3.5 Systemic Manifestations
- •13.3.6 Ophthalmic Presentation
- •13.3.7 Laser Therapy
- •13.3.8 Surgery
- •13.3.9 Visual Outcome
- •13.3.10 Screening
- •13.3.11 Survival
- •13.4 Retinal Vasculitis
- •13.5 Central Retinal Artery Occlusion
- •13.6 Summary
- •References
- •14: Trauma
- •14.1 Introduction
- •14.3 Contusion Injuries
- •14.3.1 Clinical Presentation
- •14.3.2 Types of Retinal Break
- •14.3.2.1 Dialysis
- •14.3.2.2 Pars Ciliaris Tears
- •14.3.2.3 Ragged Tear in Commotio Retinae
- •14.3.2.4 Giant Retinal Tears
- •14.3.3 Surgery
- •14.3.4 Visual Outcome
- •14.4 Rupture
- •14.4.1 Clinical Presentation
- •14.4.2 Surgery
- •14.4.3 Visual Outcome
- •14.5 Penetrating Injury
- •14.5.1 Clinical Presentation
- •14.5.1.1 Endophthalmitis
- •14.5.1.2 Retinal Detachment
- •14.5.2 Surgery
- •14.5.3 Visual Outcome
- •14.6 Trauma Scores
- •14.7 Intraocular Foreign Bodies
- •14.7.1 Clinical Presentation
- •14.7.1.1 Diagnostic Imaging
- •14.7.2 IOFB Materials
- •14.7.3 Surgery
- •14.7.4 The Primary Procedure
- •14.7.5 PPV: The Anterior Segment
- •14.7.5.1 The Lens
- •14.7.6 PPV: The Posterior Segment
- •14.7.7 The Magnet
- •14.7.8 Visual Outcome
- •14.7.9 Siderosis
- •14.8 Perforating Injury
- •14.9 Sympathetic Ophthalmia
- •14.10 Proliferative Vitreoretinopathy
- •14.11 Phthisis Bulbi
- •14.12 When Not to Operate
- •14.12.1 At Presentation
- •14.12.2 Postoperatively
- •14.13 Summary
- •References
- •15.1 Introduction
- •15.2 Dropped Nucleus
- •15.2.1 Clinical Features
- •15.2.2 Surgery
- •15.2.2.1 Primary Management
- •15.2.2.2 Vitrectomy Surgery
- •15.2.2.4 Success Rates
- •15.3 Intraocular Lens Dislocations
- •15.3.1 Clinical Presentation
- •15.3.2 Surgery
- •15.3.2.1 Removal of the IOL
- •15.4 Surgical Options for the Aphakic Eye
- •15.4.1 McCannell Sutured IOL
- •15.4.2 Iris-Clip IOL
- •15.4.3 Haptic Capture Method
- •15.4.4 Anterior Chamber IOL
- •15.4.5 Sutured Posterior Chamber IOLs
- •15.4.6 The Aphakic and Aniridic Eye
- •15.5 Postoperative Endophthalmitis
- •15.5.1 Clinical Features
- •15.5.2 Surgery
- •15.5.2.1 Vitreous Tap
- •15.5.2.2 Vitreous Biopsy
- •15.5.3 Infective Organisms
- •15.5.4 Antibiotics
- •15.5.5 The Role of Vitrectomy
- •15.5.6 Success Rates
- •15.6 Chronic Postoperative Endophthalmitis
- •15.7 Needlestick Injury
- •15.7.1 Clinical Features
- •15.7.2 Surgery
- •15.8 Intraocular Haemorrhage
- •15.9 Retinal Detachment
- •15.10 Chronic Uveitis
- •15.11 Postoperative Cystoid Macular Oedema
- •15.12 Postoperative Vitreomacular Traction
- •15.13 Postoperative Choroidal Effusion
- •15.13.1 External Drainage
- •15.14 Summary
- •References
- •16: Uveitis and Allied Disorders
- •16.1 Introduction
- •16.2 Non-infectious Uveitis of the Posterior Segment
- •16.2.2 Retinal Detachment
- •16.2.3 Cystoid Macular Oedema
- •16.2.4 Hypotony
- •16.2.5 The Vitreous Biopsy
- •16.2.6 Sampling at the Beginning of a PPV
- •16.2.6.1 Special Situations
- •16.3 Acute Retinal Necrosis
- •16.3.1 Clinical Features
- •16.3.2 Surgery
- •16.3.2.1 For Diagnosis
- •16.3.2.2 For Treatment
- •16.3.3 Visual Outcome
- •16.4 Cytomegalovirus Retinitis
- •16.4.1 Clinical Features
- •16.4.2 Surgery
- •16.4.2.1 For Diagnosis
- •16.4.2.2 For Treatment
- •16.4.3 Visual Outcome
- •16.5 Fungal Endophthalmitis
- •16.5.1 Clinical Features
- •16.5.2 Surgery
- •16.5.2.1 For Diagnosis
- •16.5.2.2 For Treatment
- •16.5.3 Visual Outcome
- •16.6 Other Infections
- •16.6.1 Clinical Features
- •16.6.2 Surgery
- •16.6.2.1 For Diagnosis
- •16.6.2.2 Chorioretinal Biopsy
- •16.6.2.3 For Treatment
- •16.6.3 Visual Outcome and Survival
- •16.7 Paraneoplastic Retinopathy
- •16.8 Summary
- •References
- •17: Miscellaneous Conditions
- •17.1 Vitrectomy for Vitreous Opacities
- •17.2 Vitreous Anomalies
- •17.2.1 Persistent Hyperplastic Primary Vitreous
- •17.2.2 Asteroid Hyalosis
- •17.2.3 Amyloidosis
- •17.3 Retinal Haemangioma and Telangiectasia
- •17.4 Optic Disc Anomalies
- •17.4.1 Optic Disc Pits and Optic Disc Coloboma
- •17.4.2 Morning Glory Syndrome
- •17.5 Retinochoroidal Coloboma
- •17.6 Marfan’s Syndrome
- •17.7 Retinopathy of Prematurity
- •17.8 Uveal Effusion Syndrome
- •17.8.1 Clinical Features
- •17.8.2 Surgery
- •17.9 Terson’s Syndrome
- •17.10 Disseminated Intravascular Coagulation
- •17.11 Retinal Prosthesis
- •17.12 Summary
- •References
- •Glossary of Abbreviations
- •Others in Database
- •Appendices
- •Useful Formulae and Rules
- •Cryotherapy
- •Fluids (i.e. Both Gases and Liquids)
- •Gases
- •Liquids
- •Ultrasound
- •Diffusion and Viscosity
- •Visual Acuity
- •Diffusion
- •Fick’s Law
- •Stokes-Einstein
- •Darcy’s Law
- •Starling’s Law
- •Index
References |
59 |
|
|
Complications
1.Endophthalmitis
(a)Bacterial
(b)Sterile
2.Vitreous haemorrhage
3.Lens damage
4. Bubbles of air in the vitreous cavity from use of silicone syringes
2.Raised IOP
(a)Volumetric
(b)Aqueous misdirection
3.Retinal detachment
4.Central retinal artery occlusion
5.Retinal pigment epithelial rip in CNV
2.23Slow Release Preparations
Injection capsules and implants have been designed usually to allow slow release of intraocular steroid. These have had variable success being associated with high rates of cataract and glaucoma, but some improvement in outcome at 6 months for diabetic retinopathy, retinal vein occlusion and uveitis (Haller et al. 2010a, b).
2.24Summary
The routine procedure is the pars plana vitrectomy which can be adapted to deal with a large variety of retinal conditions. Knowledge of the properties of the various peroperative and postoperative agents that can be employed should be obtained.
References
Abrams GW, Azen SP, Barr CC, Lai MY, Hutton WL, Trese MT, Irvine A, Ryan SJ (1995) The incidence of corneal abnormalities in the Silicone Study. Silicone Study report 7. Arch Ophthalmol 113(6):764Ð769
Afrashi F, Erakgun T, Akkin C, Kaskaloglu M, Mentes J (2004) Conventional buckling surgery or primary vitrectomy with silicone oil tamponade in rhegmatogenous retinal detachment with multiple breaks. Graefes Arch Clin Exp Ophthalmol 242(4):295Ð300
Al-Harthi E, Abboud EB, Al-Dhibi H, Dhindsa H (2005) Incidence of sclerotomy-related retinal breaks. Retina 25(3):281Ð284
Byrne S, Ng J, Hildreth A, Danjoux JP, Steel DH (2008) Refractive change following pseudophakic vitrectomy. BMC Ophthalmol 8:19. doi:10.1186/1471-2415-8-19, pii: 1471-2415-8-19
Carter JB, Michels RG, Glaser BM, de Bes S (1990) Iatrogenic retinal breaks complicating pars plana vitrectomy. Ophthalmology 97(7):848Ð853
Chandra A, Jazayeri F, Williamson TH (2011) Warfarin in vitreoretinal surgery: a case controlled series. Br J Ophthalmol. doi:10.1136/ bjo.2010.187526, pii: bjo.2010.187526
Cohen SM, Flynn HW Jr, Murray TG, Smiddy WE (1995) Endophthalmitis after pars plana vitrectomy. The Postvitrectomy Endophthalmitis Study Group. Ophthalmology 102(5):705Ð712
Dayani PN, Grand MG (2006) Maintenance of warfarin anticoagulation for patients undergoing vitreoretinal surgery. Arch Ophthalmol 124(11):1558Ð1565. doi:10.1001/archopht.124.11.1558, pii: 124/11/1558
DeBoer C, Fang S, Lima LH, McCormick M, Bhadri P, Kerns R, Humayun M (2008) Port geometry and its inßuence on vitrectomy. Retina 28(8):1061Ð1067. doi:10.1097/IAE.0b013e3181840b64, pii: 00006982-200809000-00005
Desai A, Rubinstein A, Reginald A, Parulekar M, Tanner V (2008) Feasibility of day-case vitreoretinal surgery. Eye (Lond) 22(2):169Ð 172. doi:10.1038/sj.eye.6702515, pii: 6702515
Dogramaci M, Lee EJ, Williamson TH (2012) The incidence and the risk factors for iatrogenic retinal breaks during pars plana vitrectomy. Eye (Lond). doi:10.1038/eye.2012.18, pii: eye201218
Eifrig CW, Scott IU, Flynn HW Jr, Smiddy WE, Newton J (2004) Endophthalmitis after pars plana vitrectomy: incidence, causative organisms, and visual acuity outcomes. Am J Ophthalmol 138(5):799Ð802
Falkner-Radler CI, Benesch T, Binder S (2008) Accuracy of preoperative biometry in vitrectomy combined with cataract surgery for patients with epiretinal membranes and macular holes: results of a prospective controlled clinical trial. J Cataract Refract Surg 34(10):1754Ð1760. doi:10.1016/j.jcrs.2008.06.021, pii: S0886- 3350(08)00688-3
Fang SY, DeBoer CM, Humayun MS (2008) Performance analysis of new-generation vitreous cutters. Graefes Arch Clin Exp Ophthalmol 246(1):61Ð67. doi:10.1007/s00417-007-0672-8
Fisher RF (1983) Is the vitreous necessary for accommodation in man? Br J Ophthalmol 67(3):206
Folk JC, Sneed SR, Folberg R, Coonan P, Pulido JS (1989) Early retinal adhesion from laser photocoagulation. Ophthalmology 96(10):1523Ð1525
Ghoraba HH, Zayed AI (2001) Suprachoroidal hemorrhage as a complication of vitrectomy. Ophthalmic Surg Lasers 32(4):281Ð288 Grusha YO, Masket S, Miller KM (1998) PhacoemulsiÞcation and lens
implantation after pars plana vitrectomy. Ophthalmology 105(2):287Ð294
Gupta B, Wong R, Sivaprasad S, Williamson TH (2012) Surgical and visual outcome following 20-gauge vitrectomy in proliferative diabetic retinopathy over a 10-year period, evidence for change in practice. Eye (Lond). doi:10.1038/eye.2011.348, pii: eye2011348
Haller JA, Bandello F, Belfort R Jr, Blumenkranz MS, Gillies M, Heier J, Loewenstein A, Yoon YH, Jacques ML, Jiao J, Li XY, Whitcup SM (2010a) Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology 117(6):1134Ð1146 e1133. doi:10.1016/j.ophtha.2010.03.032, pii: S0161-6420(10)00311-8
Haller JA, Kuppermann BD, Blumenkranz MS, Williams GA, Weinberg DV, Chou C, Whitcup SM (2010b) Randomized controlled trial of an intravitreous dexamethasone drug delivery system in patients with diabetic macular edema. Arch Ophthalmol 128(3):289Ð296. doi:10.1001/archophthalmol.2010.21, pii: 128/3/289
Han DP, Murphy ML, Mieler WF (1994) A modiÞed en bloc excision technique during vitrectomy for diabetic traction retinal detachment. Results and complications. Ophthalmology 101(5):803Ð808 Herbert EN, Mokete B, Williamson TH, Laidlaw DA (2006) Haemorrhagic vitreoretinal complications associated with com-
bined antiplatelet agents. Br J Ophthalmol 90(9):1209Ð1210 Hoerauf H, Roider J, Herboth T, Hager A, Laqua H (1997) Outcome
after vitrectomy in rhegmatogenous retinal detachment and dense vitreous opacities. Klin Monbl Augenheilkd 211(6):369Ð374
Holekamp NM, Shui YB, Beebe DC (2005) Vitrectomy surgery increases oxygen exposure to the lens: a possible mechanism for nuclear cataract formation. Am J Ophthalmol 139(2):302Ð310. doi:10.1016/j.ajo.2004.09.046, pii: S0002-9394(04)01147-X
Holekamp NM, Shui YB, Beebe D (2006) Lower intraocular oxygen tension in diabetic patients: possible contribution to decreased incidence of nuclear sclerotic cataract. Am J Ophthalmol 141(6):1027Ð1032
60 |
2 Introduction to Vitreoretinal Surgery |
|
|
Horiguchi M, Kojima Y, Shimada Y (2002) New system for Þberopticfree bimanual vitreous surgery. Arch Ophthalmol 120(4):491Ð494 Ibarra MS, Hermel M, Prenner JL, Hassan TS (2005) Longer-term out-
comes of transconjunctival sutureless 25-gauge vitrectomy. Am J Ophthalmol 139(5):831Ð836
Jaffe GJ (1997) Management of condensation on a foldable acrylic intraocular lens after vitrectomy and ßuid-air exchange. Am J Ophthalmol 124(5):692Ð693
Kellner L, Wimpissinger B, Stolba U, Brannath W, Binder S (2007) 25-Gauge vs 20-gauge system for pars plana vitrectomy: a prospective randomised clinical trial. Br J Ophthalmol 91(7):945Ð948. doi:10.1136/bjo.2006.106799, pii: bjo.2006.106799
Kilmartin DJ, Dick AD, Forrester JV (2000a) Prospective surveillance of sympathetic ophthalmia in the UK and Republic of Ireland. Br J Ophthalmol 84(3):259Ð263
Kilmartin DJ, Dick AD, Forrester JV (2000b) Sympathetic ophthalmia risk following vitrectomy: should we counsel patients? Br J Ophthalmol 84(5):448Ð449
Koh HJ, Cheng L, Kosobucki B, Freeman WR (2007) Prophylactic intraoperative 360 degrees laser retinopexy for prevention of retinal detachment. Retina 27(6):744Ð749. doi:10.1097/ IAE.0b013e318030ebd7, pii: 00006982-200707000-00012
Kunimoto DY, Kaiser RS (2007) Incidence of endophthalmitis after 20and 25-gauge vitrectomy. Ophthalmology 114(12):2133Ð2137. doi:10.1016/j.ophtha.2007.08.009, pii: S0161-6420(07)00862-7
Kuo HK, Lee JJ (2009) Macular infarction after 23-gauge transconjunctival sutureless vitrectomy and subconjunctival gentamicin for macular pucker: a case report. Can J Ophthalmol 44(6):720Ð721. doi:10.1139/i09-197, pii: i09-197
Lakhanpal V, Schocket SS, Elman MJ, Dogra MR (1990) Intraoperative massive suprachoroidal hemorrhage during pars plana vitrectomy. Ophthalmology 97(9):1114Ð1119
Machemer R, Buettner H, Norton EW, Parel JM (1971) Vitrectomy: a pars plana approach. Trans Am Acad Ophthalmol Otolaryngol 75(4):813Ð820
Machemer R, Parel JM, Norton EW (1972) Vitrectomy: a pars plana approach. Technical improvements and further results. Trans Am Acad Ophthalmol Otolaryngol 76(2):462Ð466
Magalhaes O Jr, Chong L, DeBoer C, Bhadri P, Kerns R, Barnes A, Fang S, Humayun M (2008) Vitreous dynamics: vitreous ßow analysis in 20-, 23-, and 25-gauge cutters. Retina 28(2):236Ð241. doi:10.1097/ IAE.0b013e318158e9e0, pii: 00006982-200802000-00006
Mason JO 3rd, Gupta SR, Compton CJ, Frederick PA, Neimkin MG, Hill ML, Heersink MJ, Vail RS, White MF Jr, Feist RM, Thomley ML, Albert MA Jr (2010) Comparison of hemorrhagic complications of warfarin and clopidogrel bisulfate in 25-gauge vitrectomy versus a control group. Ophthalmology 118(3):543Ð547. doi:10.1016/j.ophtha.2010.07.005, pii: S0161-6420(10)00720-7
Morley AM, Pavesio C (2008) Surgically induced necrotising scleritis following three-port pars plana vitrectomy without scleral buckling: a series of three cases. Eye (Lond) 22(1):162Ð164. doi:10.1038/sj. eye.6702708, pii: 6702708
Narendran N, Williamson TH (2003) The effects of aspirin and warfarin therapy on haemorrhage in vitreoretinal surgery. Acta Ophthalmol Scand 81(1):38Ð40
Okuda T, Nishimura A, Kobayashi A, Sugiyama K (2007) Postoperative retinal break after 25-gauge transconjunctival sutureless vitrectomy: report of four cases. Graefes Arch Clin Exp Ophthalmol 245(1):155Ð 157. doi:10.1007/s00417-006-0354-y
Peyman GA, Salzano TC, Green JL Jr (1981) Argon endolaser. Arch Ophthalmol 99(11):2037Ð2038
Rich RM, Smiddy WE, Davis JL (2008) Infectious scleritis after retinal surgery. Am J Ophthalmol 145(4):695Ð699. doi:10.1016/j. ajo.2007.11.024, pii: S0002-9394(07)01008-2
Sato T, Kusaka S, Oshima Y, Fujikado T (2008) Analyses of cutting and aspirating properties of vitreous cutters with high-speed camera.
Retina 28(5):749Ð754. doi:10.1097/IAE.0b013e3181631907, pii: 00006982-200805000-00013
Schachat AP, Oyakawa RT, Michels RG, Rice TA (1983) Complications of vitreous surgery for diabetic retinopathy. II. Postoperative complications. Ophthalmology 90(5):522Ð530
Senn P, Schipper I, Perren B (1995) Combined pars plana vitrectomy, phacoemulsiÞcation, and intraocular lens implantation in the capsular bag: a comparison to vitrectomy and subsequent cataract surgery as a two-step procedure. Ophthalmic Surg Lasers 26(5):420Ð428
Sharma T, Virdi DS, Parikh S, Gopal L, Badrinath SS, Mukesh BN (1997) A case-control study of suprachoroidal hemorrhage during pars plana vitrectomy. Ophthalmic Surg Lasers 28(8):640Ð644
Shinoda K, OÕHira A, Ishida S, Hoshide M, Ogawa LS, Ozawa Y, Nagasaki K, Inoue M, Katsura H (2001) Posterior synechia of the iris after combined pars plana vitrectomy, phacoemulsiÞcation, and intraocular lens implantation. Jpn J Ophthalmol 45(3):276Ð280, pii: S0021-5155(01)00319-7
Shunmugam M, Shunmugam S, Williamson TH, Laidlaw DA (2011) Air-gas exchange reevaluated: clinically important results of a computer simulation. Invest Ophthalmol Vis Sci 52(11):8262Ð8265. doi:10.1167/iovs.11-8258, pii: iovs.11-8258
Sjaarda RN, Glaser BM, Thompson JT, Murphy RP, Hanham A (1995) Distribution of iatrogenic retinal breaks in macular hole surgery. Ophthalmology 102(9):1387Ð1392
Spitznas M (1987) A binocular indirect ophthalmomicroscope (BIOM) for non-contact wide-angle vitreous surgery. Graefes Arch Clin Exp Ophthalmol 225(1):13Ð15
Stein JD, Zacks DN, Grossman D, Grabe H, Johnson MW, Sloan FA (2009) Adverse events after pars plana vitrectomy among Medicare beneÞciaries. Arch Ophthalmol 127(12):1656Ð1663. doi:10.1001/ archophthalmol.2009.300, pii: 127/12/1656
Sugisaka E, Shinoda K, Ishida S, Imamura Y, Ozawa Y, Shinoda H, Suzuki K, Tsubota K, Inoue M (2007) PatientsÕ descriptions of visual sensations during pars plana vitrectomy under retrobulbar anesthesia. Am J Ophthalmol 144(2):245Ð251. doi:10.1016/j. ajo.2007.05.001, pii: S0002-9394(07)00433-3
Suzuki Y, Sakuraba T, Mizutani H, Matsuhashi H, Nakazawa M (2000) Postoperative refractive error after simultaneous vitrectomy and cataract surgery. Ophthalmic Surg Lasers 31(4):271Ð275
Suzuki Y, Sakuraba T, Mizutani H, Matsuhashi H, Nakazawa M (2001) Postoperative complications after simultaneous vitrectomy and cataract surgery. Ophthalmic Surg Lasers 32(5):391Ð396
Tabandeh H, Sullivan PM, Smahliuk P, Flynn HW Jr, Schiffman J (1999) Suprachoroidal hemorrhage during pars plana vitrectomy. Risk factors and outcomes. Ophthalmology 106(2):236Ð242
Thompson JT (2004) The role of patient age and intraocular gas use in cataract progression after vitrectomy for macular holes and epiretinal membranes. Am J Ophthalmol 137(2):250Ð257. doi:10.1016/j. ajo.2003.09.020, pii: S0002939403010948
Treumer F, Bunse A, Rudolf M, Roider J (2006) Pars plana vitrectomy, phacoemulsiÞcation and intraocular lens implantation. Comparison of clinical complications in a combined versus two-step surgical approach. Graefes Arch Clin Exp Ophthalmol 244(7):808Ð815. doi:10.1007/s00417-005-0146-9
Wallenten KG, Andreasson S, Ghosh F (2008) Retinal function after vitrectomy.Retina28(4):558Ð563.doi:10.1097/IAE.0b013e31815e9890, pii: 00006982-200804000-00005
Wimpissinger B, Kellner L, Brannath W, Krepler K, Stolba U, Mihalics C, Binder S (2008) 23-gauge versus 20-gauge system for pars plana vitrectomy: a prospective randomised clinical trial. Br J Ophthalmol 92(11):1483Ð1487. doi:10.1136/bjo.2008.140509, pii: bjo.2008.140509 Wykoff CC, Parrott MB, Flynn HW Jr, Shi W, Miller D, Alfonso EC (2010) Nosocomial acute-onset postoperative endophthalmitis at a university teaching hospital (2002Ð2009). Am J Ophthalmol 150(3):392Ð398 e392. doi:10.1016/j.ajo.2010.04.010, pii: S0002-
9394(10)00266-7
